BRD4

bromodomain containing 4, the group of Bromodomain and extra-terminal domain family|Bromodomain containing

Basic information

Region (hg38): 19:15235519-15332545

Links

ENSG00000141867NCBI:23476OMIM:608749HGNC:13575Uniprot:O60885AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Cornelia de Lange syndrome (Supportive), mode of inheritance: AD
  • multiple congenital anomalies/dysmorphic syndrome (Limited), mode of inheritance: AD
  • syndromic intellectual disability (Definitive), mode of inheritance: AD
  • Cornelia de Lange syndrome 6 (Strong), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Cornelia de Lange syndrome 6ADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Musculoskeletal; Neurologic29379197; 35470444

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the BRD4 gene.

  • not_provided (713 variants)
  • Inborn_genetic_diseases (73 variants)
  • BRD4-related_disorder (41 variants)
  • Cornelia_de_Lange_syndrome_6 (11 variants)
  • not_specified (10 variants)
  • De_Lange_syndrome (7 variants)
  • Syndromic_intellectual_disability (2 variants)
  • Mental_disorder (2 variants)
  • Short_stature (2 variants)
  • Cornelia_de_Lange-like_syndrome (2 variants)
  • Neurodevelopmental_disorder (1 variants)
  • Learning_Disabilities,_Adolescent (1 variants)
  • Cornelia_de_Lange_syndrome_1 (1 variants)
  • Intellectual_disability (1 variants)
  • See_cases (1 variants)
  • Developmental_disorder (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the BRD4 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001379291.1. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
4
clinvar
236
clinvar
20
clinvar
261
missense
1
clinvar
3
clinvar
307
clinvar
22
clinvar
6
clinvar
339
nonsense
2
clinvar
1
clinvar
3
start loss
0
frameshift
8
clinvar
9
clinvar
2
clinvar
19
splice donor/acceptor (+/-2bp)
1
clinvar
1
clinvar
1
clinvar
3
Total 13 14 314 258 26

Highest pathogenic variant AF is 0.00008557736

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
BRD4protein_codingprotein_codingENST00000263377 1995710
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.001.83e-10125742021257440.00000795
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense3.595198050.6440.00005058836
Missense in Polyphen814.8340.53929142
Synonymous-3.624263411.250.00002442678
Loss of Function7.27061.50.000.00000319689

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.0001020.0000992
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00001760.00000879
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Chromatin reader protein that recognizes and binds acetylated histones and plays a key role in transmission of epigenetic memory across cell divisions and transcription regulation. Remains associated with acetylated chromatin throughout the entire cell cycle and provides epigenetic memory for postmitotic G1 gene transcription by preserving acetylated chromatin status and maintaining high-order chromatin structure. During interphase, plays a key role in regulating the transcription of signal-inducible genes by associating with the P- TEFb complex and recruiting it to promoters: BRD4 is required to form the transcriptionally active P-TEFb complex by displacing negative regulators such as HEXIM1 and 7SKsnRNA complex from P- TEFb, thereby transforming it into an active form that can then phosphorylate the C-terminal domain (CTD) of RNA polymerase II. Promotes phosphorylation of 'Ser-2' of the C-terminal domain (CTD) of RNA polymerase II. According to a report, directly acts as an atypical protein kinase and mediates phosphorylation of 'Ser-2' of the C-terminal domain (CTD) of RNA polymerase II; these data however need additional evidences in vivo (PubMed:22509028). In addition to acetylated histones, also recognizes and binds acetylated RELA, leading to further recruitment of the P-TEFb complex and subsequent activation of NF-kappa-B. Also acts as a regulator of p53/TP53-mediated transcription: following phosphorylation by CK2, recruited to p53/TP53 specific target promoters. {ECO:0000269|PubMed:22509028}.;
Disease
DISEASE: Note=A chromosomal aberration involving BRD4 is found in a rare, aggressive, and lethal carcinoma arising in midline organs of young people. Translocation t(15;19)(q14;p13) with NUT which produces a BRD4-NUT fusion protein. {ECO:0000269|PubMed:11733348, ECO:0000269|PubMed:12543779}.;
Pathway
Chemical Compounds to monitor Proteins (Consensus)

Recessive Scores

pRec
0.187

Intolerance Scores

loftool
0.363
rvis_EVS
-1.48
rvis_percentile_EVS
3.69

Haploinsufficiency Scores

pHI
0.428
hipred
Y
hipred_score
0.831
ghis
0.614

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.963

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Brd4
Phenotype
craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; liver/biliary system phenotype; skeleton phenotype; vision/eye phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype;

Zebrafish Information Network

Gene name
brd4
Affected structure
thrombocyte
Phenotype tag
abnormal
Phenotype quality
decreased amount

Gene ontology

Biological process
regulation of transcription involved in G1/S transition of mitotic cell cycle;chromatin organization;protein phosphorylation;cellular response to DNA damage stimulus;positive regulation of G2/M transition of mitotic cell cycle;viral process;positive regulation of transcription elongation from RNA polymerase II promoter;positive regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;regulation of inflammatory response;regulation of phosphorylation of RNA polymerase II C-terminal domain;positive regulation of histone H3-K36 trimethylation
Cellular component
condensed nuclear chromosome;nucleus;nucleoplasm;cytosol
Molecular function
p53 binding;chromatin binding;protein binding;RNA polymerase II CTD heptapeptide repeat kinase activity;enzyme binding;lysine-acetylated histone binding;RNA polymerase II C-terminal domain binding